| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.59 | 0.002 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.52 | 0.003 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.45 | 0.008 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.001 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.37 | 0.06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.33 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-07 |